Spineway SA (EPA:ALSPW)
France · Delayed Price · Currency is EUR 0.1402
+0.0080 (6.05%)
Jul 21, 2026, 5:35 PM CET
Spineway Revenue
In the year 2025, Spineway had annual revenue of 12.43M EUR with 4.02% growth. Spineway had revenue of 6.86M in the half year ending December 31, 2025, with 34.79% growth.
Revenue
12.43M
Revenue Growth
+4.02%
P/S Ratio
0.21
Revenue / Employee
297.95K
Employees
43
Market Cap
2.63M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.43M | 480.00K | 4.02% |
| Dec 31, 2024 | 11.95M | 1.43M | 13.60% |
| Dec 31, 2023 | 10.52M | 5.26M | 100.13% |
| Dec 31, 2022 | 5.26M | 966.16K | 22.52% |
| Dec 31, 2021 | 4.29M | 911.00K | 26.96% |
| Dec 31, 2020 | 3.38M | -1.64M | -32.66% |
| Dec 31, 2019 | 5.02M | -1.50M | -22.98% |
| Dec 31, 2018 | 6.52M | -2.62M | -28.70% |
| Dec 31, 2017 | 9.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 47.35B |
| EssilorLuxottica Société anonyme | 28.49B |
| Ipsen | 3.93B |
| Sartorius Stedim Biotech | 2.98B |
| Bluelinea Société Anonyme | 11.12M |
| Oncodesign Precision Medicine Société anonyme | 1.81M |
| Predilife | 835.81K |
| bonyf | 309.37K |
Spineway News
- 2 months ago - Spineway Earnings release: Q1 2026 - Filings
- 5 months ago - Spineway Earnings release: Q4 2025 - Filings
- 6 months ago - Spineway Earnings release: Q4 2025 - Filings
- 10 months ago - Spineway Earnings release: Q3 2025 - Filings
- 1 year ago - Spineway Earnings release: H1 2025 - Filings